102 related articles for article (PubMed ID: 2371898)
21. The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat.
Frijlink HW; Visser J; Hefting NR; Oosting R; Meijer DK; Lerk CF
Pharm Res; 1990 Dec; 7(12):1248-52. PubMed ID: 2095562
[TBL] [Abstract][Full Text] [Related]
22. Influencing of resorption and side-effects of salicylic acid by complexing with beta-cyclodextrin.
Szejtli J; Gerlóczy A; Sebestyén G; Fónagy A
Pharmazie; 1981 Apr; 36(4):283-6. PubMed ID: 7255530
[TBL] [Abstract][Full Text] [Related]
23. Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation.
Murthy SN; Zhao YL; Sen A; Hui SW
J Control Release; 2004 Oct; 99(3):393-402. PubMed ID: 15451597
[TBL] [Abstract][Full Text] [Related]
24. Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
Reginster JY; Franchimont P
Eur J Rheumatol Inflamm; 1993; 12(4):38-46. PubMed ID: 7805703
[TBL] [Abstract][Full Text] [Related]
25. [Application of beta-cyclodextrin during direct pressing of tablets].
Szabóné RP; Pintyéné HK; Kun L; Miseta M; Selmeczi B
Acta Pharm Hung; 1989 May; 59(3):99-107. PubMed ID: 2763849
[TBL] [Abstract][Full Text] [Related]
26. Disposition of [14C]gamma-cyclodextrin in germ-free and conventional rats.
De Bie AT; Van Ommen B; Bär A
Regul Toxicol Pharmacol; 1998 Apr; 27(2):150-8. PubMed ID: 9671569
[TBL] [Abstract][Full Text] [Related]
27. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
Warrington S
Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
[TBL] [Abstract][Full Text] [Related]
28. [Spray embedding of vinpocetin with beta-cyclodextrin].
Kata M; György E
Pharmazie; 1982 May; 37(5):386-7. PubMed ID: 7111372
[No Abstract] [Full Text] [Related]
29. [Beta-cyclodextrin as an auxiliary substance in tabletting (preliminary communication)].
Krajnyák J; Rácz I; Dávid A; Szejtli J
Acta Pharm Hung; 1984 Mar; 54(2):90-1. PubMed ID: 6730980
[No Abstract] [Full Text] [Related]
30. [Use of a sulfamethoxazole-beta-cyclodextrin complex in suppositories].
Tóth K; Apostol I
Acta Pharm Hung; 1986 May; 56(3):133-7. PubMed ID: 3739726
[No Abstract] [Full Text] [Related]
31. [Molecular cavity filling and tabletting with beta-cyclodextrin].
Hüttenrauch R; Fricke S
Pharmazie; 1985 May; 40(5):361-2. PubMed ID: 4034643
[No Abstract] [Full Text] [Related]
32. Hemicrania continua: a case responsive to piroxicam-beta-cyclodextrin.
Trucco M; Antonaci F; Sandrini G
Headache; 1992 Jan; 32(1):39-40. PubMed ID: 1555930
[TBL] [Abstract][Full Text] [Related]
33. [Stabilization of chlorobutanol with beta-cyclodextrin in suppositories].
Gyulai M; Apostol I
Acta Pharm Hung; 1986 May; 56(3):125-8. PubMed ID: 3739724
[No Abstract] [Full Text] [Related]
34. Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol.
Loftsson T; Bodor N
Acta Pharm Nord; 1989; 1(4):185-94. PubMed ID: 2590460
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of stability and biological effect on cholecalciferol by beta-cyclodextrin complexation.
Szejtli J; Bolla-Pusztai E; Szabó P; Ferenczy T
Pharmazie; 1980 Dec; 35(12):779-87. PubMed ID: 6259671
[No Abstract] [Full Text] [Related]
36. [Inclusion compounds of 8 Chinese medicinal volatile oils with beta-cyclodextrin].
Li SZ; Guan SJ
Zhong Yao Tong Bao; 1987 Dec; 12(12):27-32, 58-9. PubMed ID: 3446391
[No Abstract] [Full Text] [Related]
37. Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.
Lee CR; Balfour JA
Drugs; 1994 Dec; 48(6):907-29. PubMed ID: 7533698
[TBL] [Abstract][Full Text] [Related]
38. Wettability of cyclodextrin complexes.
Szente L; Szejtli J
Acta Pharm Hung; 1987 Mar; 57(1-2):73-6. PubMed ID: 3591344
[No Abstract] [Full Text] [Related]
39. beta-Cyclodextrin: promoting effect on the development of renal tubular cell tumors in rats treated with N-ethyl-N-hydroxyethylnitrosamine.
Hiasa Y; Ohshima M; Kitahori Y; Konishi N; Fujita T; Yuasa T
J Natl Cancer Inst; 1982 Oct; 69(4):963-7. PubMed ID: 6956770
[TBL] [Abstract][Full Text] [Related]
40. Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration.
Patoia L; Clausi G; Farroni F; Alberti P; Fugiani P; Bufalino L
Eur J Clin Pharmacol; 1989; 36(6):599-604. PubMed ID: 2673795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
